Richard Priestley
About Richard Priestley
Richard Priestley is a Senior Scientist specializing in GPCR pharmacology at Exscientia, with a background in pharmacology and extensive experience in drug discovery. He has held various research positions across notable institutions, including the University of Oxford and Pfizer Neusentis.
Work at Exscientia
Richard Priestley currently holds the position of Senior Scientist specializing in GPCR Pharmacology at Exscientia. He has been with the company since 2021 and is based in Oxford, England. His role involves applying his expertise in pharmacology to support drug discovery initiatives, particularly focusing on G protein-coupled receptors, which are critical targets in the development of new therapeutics.
Education and Expertise
Richard Priestley earned his Bachelor of Science degree in Pharmacology from The University of Edinburgh, where he studied from 2005 to 2009. He further pursued a Ph.D. in Biomedical Sciences at the University of Nottingham from 2010 to 2014. His educational background is complemented by advanced skills in pharmacological, biochemical, and cell-culture-based laboratory techniques, making him proficient in various aspects of drug discovery.
Background
Richard Priestley has a diverse professional background in pharmacology and scientific research. Before his current role at Exscientia, he worked at several institutions, including the University of Oxford as a Postdoctoral Research Associate from 2017 to 2021. He also held positions at Pfizer Neusentis, Syntaxin Ltd, Liverpool School of Tropical Medicine, and Almac Group, contributing to various research projects and gaining extensive experience in the field.
Achievements in Drug Discovery
Throughout his career, Richard Priestley has contributed to drug discovery projects targeting neurodegenerative disorders, pain, and tropical diseases. His work has focused on GPCR pharmacology, a significant area in drug discovery that involves studying G protein-coupled receptors. His contributions have supported advancements in understanding and developing new therapeutic options for complex health issues.
Previous Roles and Research Experience
Prior to his current position, Richard Priestley gained valuable research experience in various roles. He served as a Postdoctoral Researcher at the Liverpool School of Tropical Medicine and the University of Oxford. His earlier career included a role as a Pharmacologist at Syntaxin Ltd and a Molecular Biology Laboratory Technician at Almac Group. These positions have provided him with a solid foundation in pharmacological research and assay development.